AJR Am J Roentgenol

1. GRADY E, Pattison DA, Redman S, Satoh Y, et al
   The Global Reading Room: Performing a Ventilation-Perfusion Study in a Patient With Recent COVID-19.
   AJR Am J Roentgenol. 2024 May 1. doi: 10.2214/AJR.24.31348.
   

   >> Share

   
   

   
   Am J Obstet Gynecol

2. MAGNUS MC, Rasmussen TD, Ortqvist AK, Oakley LL, et al
   Covid-19 vaccination during pregnancy is not associated with an increased risk of severe post-partum hemorrhage.
   Am J Obstet Gynecol. 2024 Apr 30:S0002-9378(24)00554.
   

   >> Share

   
   

   
   Am J Respir Crit Care Med

3. AZOULAY E, Pochard F, Argaud L, Kentish-Barnes N, et al
   Reply to Zijlstra: Resilience and Stress Are Heterogenic Too, We Should Act Accordingly.
   Am J Respir Crit Care Med. 2024 May 3. doi: 10.1164/rccm.202404-0790.
   

   >> Share

   
   

   
   Antiviral Res

4. LIU X, Wang Y, Sun L, Xiao G, et al
   Screening and optimization of shark nanobodies against SARS-CoV-2 Spike RBD.
   Antiviral Res. 2024 Apr 29:105898. doi: 10.1016/j.antiviral.2024.105898.
   

   >> Share

   
   
5. ARDUINO I, Francese R, Civra A, Feyles E, et al
   Polyoxometalate exerts broad-spectrum activity against human respiratory viruses hampering viral entry.
   Antiviral Res. 2024;226:105897.
   

   >> Share

   
   
6. AMERATUNGA R, Jordan A, Lehnert K, Leung E, et al
   SARS-CoV-2 evolution has increased resistance to monoclonal antibodies and first-generation COVID-19 vaccines: Is there a future therapeutic role for soluble ACE2 receptors for COVID-19?
   Antiviral Res. 2024 Apr 25:105894. doi: 10.1016/j.antiviral.2024.105894.
   

   >> Share

   
   

   
   BMJ

7. SILLETT JM
   Perhaps politicians and health leaders could #sayhellotopatients?
   BMJ. 2024;385:q976.
   

   >> Share

   
   
8. MATHEW R
   Rammya Mathew: We can't overlook the backdrop as Britain becomes "a sicker nation".
   BMJ. 2024;385:q956.
   

   >> Share

   
   
9. WISE J
   MP resigns from Tory party over NHS "stretched close to breaking point".
   BMJ. 2024;385:q983.
   

   >> Share

   
   
10. MIDDLETON J, Saunders P
    What will it take for a new sanitary revolution in the UK?
    BMJ. 2024;385:q974.
    

    >> Share

    
    
11. MORGAN SG
    When will Canada have national pharmacare?
    BMJ. 2024;385:q887.
    

    >> Share

    
    
12. TANNE JH
    US pregnant workers get new legal protections, but not paid time off.
    BMJ. 2024;385:q926.
    

    >> Share

    
    
13. MAHASE E
    Doctors will shape Labour's 10 year plan to fix NHS crisis, says shadow health secretary.
    BMJ. 2024;385:q980.
    

    >> Share

    
    
14. MCCARTNEY M, Liu PJ, Fearfull A, Macdonald H, et al
    Early diagnosis is not always an unmitigated good, we need to make it useful for patients and clinicians.
    BMJ. 2024;385:q973.
    

    >> Share

    
    
15. 
    Clinical effectiveness of an online supervised group physical and mental health rehabilitation programme for adults with post-covid-19 condition (REGAIN study): multicentre randomised controlled trial.
    BMJ. 2024;385:q988.
    

    >> Share

    
    
16. LANG K
    What do we know about covid-19's effects on the gut?
    BMJ. 2024;385:q842.
    

    >> Share

    
    
17. 
    Seven days in medicine: 24-30 April 2024.
    BMJ. 2024;385:q969.
    

    >> Share

    
    

    
    Br J Anaesth

18. BOWDLE A, Brosseau LM, Tellier R, MacIntyre CR, et al
    Reducing airborne transmissible diseases in perioperative environments.
    Br J Anaesth. 2024 Apr 26:S0007-0912(24)00181-8. doi: 10.1016/j.bja.2024.
    

    >> Share

    
    

    
    Clin Infect Dis

19. JORGENSEN SCJ, Brown K, Clarke AE, Schwartz KL, et al
    The Effect of COVID-19 Vaccination on Outpatient Antibiotic Prescribing in Older Adults: A Self-Controlled Risk-Interval Study.
    Clin Infect Dis. 2024 May 3:ciae182. doi: 10.1093.
    

    >> Share

    
    
20. BRAMANTE CT, Beckman KB, Mehta T, Karger AB, et al
    Favorable Antiviral Effect of Metformin on Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of Coronavirus Disease 2019.
    Clin Infect Dis. 2024 May 1:ciae159. doi: 10.1093.
    

    >> Share

    
    
21. SIEDNER MJ, Sax PE
    Repurposing Revisited: Exploring the Role of Metformin for Treatment of Coronavirus Disease 2019.
    Clin Infect Dis. 2024 May 1:ciae154. doi: 10.1093.
    

    >> Share

    
    
22. 
    Correction to: Impact of Seasonal Coronavirus Antibodies on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Responses in Solid Organ Transplant Recipients.
    Clin Infect Dis. 2024 Apr 30:ciae164. doi: 10.1093.
    

    >> Share

    
    
23. 
    Correction to: Differential Cytokine Signatures of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Influenza Infection Highlight Key Differences in Pathobiology.
    Clin Infect Dis. 2024 Apr 30:ciae166. doi: 10.1093.
    

    >> Share

    
    

    
    Int J Infect Dis

24. XIE H, Zhang J, Bai S, Lv M, et al
    The contributions of vaccination and natural infection to the production of neutralizing antibodies against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) prototype strain and variants.
    Int J Infect Dis. 2024 Apr 24:107060. doi: 10.1016/j.ijid.2024.107060.
    

    >> Share

    
    
25. MARTINEZ-FIERRO ML, Perez-Favila A, Alfaro SMZ, Oropeza-de Lara SA, et al
    Gene variants rs5182, rs2074192, and rs4343 in the Renin-Angiotensin-Aldosterone system are associated with symptom severity, higher odds of hospitalization, and death in COVID-19.
    Int J Infect Dis. 2024 Apr 30:107067. doi: 10.1016/j.ijid.2024.107067.
    

    >> Share

    
    
26. YAN X, Zhao X, Du Y, Wang H, et al
    Dynamics of anti-SARS-CoV-2 IgG antibody responses following breakthrough infection and the predicted protective efficacy: a longitudinal community-based population study in China.
    Int J Infect Dis. 2024 Apr 30:107075. doi: 10.1016/j.ijid.2024.107075.
    

    >> Share

    
    
27. MURRAY HC, Muleme M, Cooper D, McNamara BJ, et al
    Prevalence, risk factors and outcomes of secondary infections among hospitalised patients with COVID-19 or post-COVID-19 conditions in Victoria, 2020-2023.
    Int J Infect Dis. 2024 Apr 30:107078. doi: 10.1016/j.ijid.2024.107078.
    

    >> Share

    
    

    
    J Med Virol

28. ZHAO XJ, Liu XL, Liang YM, Zhang S, et al
    Epidemiological characteristics and antibody kinetics of elderly population with booster vaccination following both Omicron BA.5 and XBB waves in China.
    J Med Virol. 2024;96:e29640.
    

    >> Share

    
    
29. TANG Z, Mao Y, Ruan P, Li J, et al
    Drugs targeting CMPK2 inhibit pyroptosis to alleviate severe pneumonia caused by multiple respiratory viruses.
    J Med Virol. 2024;96:e29643.
    

    >> Share

    
    
30. MATUSALI G, Mazzotta V, Meschi S, Colavita F, et al
    JN.1 neutralizing antibody titers after XBB.1.5 monovalent vaccine boost in healthcare workers and people with HIV.
    J Med Virol. 2024;96:e29631.
    

    >> Share

    
    
31. GAO R, Feng C, Sheng Z, Li F, et al
    Research progress in Fc-effector functions against SARS-CoV-2.
    J Med Virol. 2024;96:e29638.
    

    >> Share

    
    
32. WANG F, Gao Y, Wagner AL, Lu Y, et al
    A systematic review and meta-analysis of herpes zoster occurrence/recurrence after COVID-19 infection and vaccination.
    J Med Virol. 2024;96:e29629.
    

    >> Share

    
    
33. THOMAS S, Smatti MK, Alsulaiti H, Zedan HT, et al
    Antibody-dependent enhancement (ADE) of SARS-CoV-2 in patients exposed to MERS-CoV and SARS-CoV-2 antigens.
    J Med Virol. 2024;96:e29628.
    

    >> Share

    
    

    
    Lancet

34. GREEN A
    Tobias Welte.
    Lancet. 2024;403:1626.
    

    >> Share

    
    
35. ADEPOJU P
    Moderna stalls on African vaccine manufacturing plans.
    Lancet. 2024;403:1617.
    

    >> Share

    
    
36. MARCHALIK D, Rehm D
    On not cutting corners.
    Lancet. 2024;403:1623.
    

    >> Share

    
    

    
    Lancet Infect Dis

37. KEDDY KH, Tadesse BT
    Inaccessible: health, wealth, governance, and equity in low-income and middle-income countries.
    Lancet Infect Dis. 2024;24:444-445.
    

    >> Share

    
    
38. KOCHER K, Moosmann C, Drost F, Schulein C, et al
    Adaptive immune responses are larger and functionally preserved in a hypervaccinated individual.
    Lancet Infect Dis. 2024;24:e272-e274.
    

    >> Share

    
    
39. LIN DY, Huang S, Milinovich A, Duggal A, et al
    Effectiveness of XBB.1.5 vaccines and antiviral drugs against severe outcomes of omicron infection in the USA.
    Lancet Infect Dis. 2024;24:e278-e280.
    

    >> Share

    
    
40. DE AMBROGI M
    A summer cold.
    Lancet Infect Dis. 2024;24:461.
    

    >> Share

    
    
41. KAZI F, Mushtaq A
    Nuria Izquierdo-Useros-fighting the good fight.
    Lancet Infect Dis. 2024;24:458.
    

    >> Share

    
    
42. MOODY J
    On the frontline during the COVID-19 pandemic.
    Lancet Infect Dis. 2024;24:464.
    

    >> Share

    
    
43. VISSER LG
    Identifying efficacious SARS-CoV-2 antivirals in a changing immune landscape.
    Lancet Infect Dis. 2024 Apr 24:S1473-3099(24)00254.
    

    >> Share

    
    
44. WONGNAK P, Schilling WHK, Jittamala P, Boyd S, et al
    Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV).
    Lancet Infect Dis. 2024 Apr 24:S1473-3099(24)00183.
    

    >> Share

    
    
45. VENKATESAN P
    Tobias Welte.
    Lancet Infect Dis. 2024;24:457.
    

    >> Share

    
    

    
    MMWR Morb Mortal Wkly Rep

46. XIE AG, Yomogida K, Berry I, Briggs NL, et al
    Notes from the Field: Increase in Nontoxigenic Corynebacterium diphtheriae - Washington, 2018-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:405-407.
    

    >> Share

    
    

    
    Nature

47. CALLAWAY E
    Scientists tried to give people COVID - and failed.
    Nature. 2024 May 1. doi: 10.1038/d41586-024-01284.
    

    >> Share

    
    
48. MALLAPATY S
    Chinese virologist who was first to share COVID-19 genome sleeps on street after lab shuts.
    Nature. 2024 May 1. doi: 10.1038/d41586-024-01293.
    

    >> Share

    
    
49. LENHARO M, Wolf L
    Controversial virus-hunting scientist skewered at US COVID-origins hearing.
    Nature. 2024 May 1. doi: 10.1038/d41586-024-01305.
    

    >> Share

    
    

    
    Radiology

50. SUTHAR PP, Hughes K, Mafraji M, Akyuz M, et al
    Case 324: CHANTER Syndrome.
    Radiology. 2024;311:e222748.
    

    >> Share

    
    

    
    Science

51. CICERO A, Phelan A
    A pandemic agreement is within reach.
    Science. 2024;384:489.
    

    >> Share

    
    
52. LYNTERIS C
    Pandemics and their accelerantsThe Human Disease: How We Create Pandemics, from Our Bodies to Our Beliefs Sabrina Sholts MIT Press, 2024. 352 pp.
    Science. 2024;384:517.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share